Case Report: Recurrent supraglottitis in a patient with metastatic melanoma treated with ipilimumab and nivolumab

BackgroundImmune checkpoint inhibitors (ICIs) are a standard of care for advanced melanoma but have the potential to cause immune-related adverse events (irAEs), which can vary widely in character and severity. Immune-related airway disease, such as supraglottitis, is a lesser-known and likely under...

全面介紹

書目詳細資料
發表在:Frontiers in Oncology
Main Authors: Marisa Palmeri, Sarah A. Weiss, Phillip Purnell
格式: Article
語言:英语
出版: Frontiers Media S.A. 2025-08-01
主題:
在線閱讀:https://www.frontiersin.org/articles/10.3389/fonc.2025.1615835/full